2026-04-13T01:38:30Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/72062025-10-24T10:59:08Zcom_2072_451665com_2072_378040col_2072_451666

SARS-CoV-2 Vaccines and the Skin Galván Casas, Cristina Català, A. Muñoz Santos, Carlos [Galván-Casas C] Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain. [Català A] Servicio de Dermatología, Sede Plató, Hospital Clínic, Barcelona, Spain. [Muñoz-Santos C] Servicio de Dermatología, Hospital General de Granollers, Granollers, Spain Hospital General de Granollers COVID-19 (Malaltia) Vacunes Pell - Malalties CHEMICALS AND DRUGS::Complex Mixtures::Biological Products::Vaccines DISEASES::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Skin Manifestations DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections COMPUESTOS QUÍMICOS Y DROGAS::mezclas complejas::productos biológicos::vacunas ENFERMEDADES::afecciones patológicas, signos y síntomas::signos y síntomas::manifestaciones cutáneas ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Skin reactions; Vacines Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reacciones cutáneas; Vacunas Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Reaccions cutànies; Vacunes Vaccines against the severe acute respiratory coronavirus 2, which are the first to be used in humans against any coronavirus, were developed and produced in record time. Dermatologic adverse effects appeared during clinical trials and have also been described in the population since approval. Just as descriptions and categorization of skin manifestations of the coronavirus disease 2019 proved important for understanding the disease itself, characterizing the effects of vaccines may also further that goal. This paper reviews the properties of the different types of vaccines currently available and under development and describes how they interact with the immune system and the clinical signs they may cause. We focus on dermatologic adverse effects reported to date and recommendations for managing them. 2022-03-18T08:56:47Z 2022-03-18T08:56:47Z 2021-10-01 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Galván-Casas C, Català A, Muñoz-Santos C. SARS-CoV-2 Vaccines and the Skin. Actas Dermosifiliogr. 2021 Oct;112(9):828-836. 0001-7310 https://hdl.handle.net/11351/7206 10.1016/j.adengl.2021.07.028 34483343 http://hdl.handle.net/11351/7206 eng Actas dermo-sifiliográficas;112(9) https://doi.org/10.1016/j.adengl.2021.07.028 Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess application/pdf Elsevier España Scientia